AKT1 and Graves disease: Moreover, Graves’ disease is considered as the consequence of a breakdown in TSHR tolerance, and selected cleavage TSHR antibody could produce a robust effect on the MAPK/PI3K-AKT/mTOR/S6K signaling cascades, the maintenance of which determined the thyroid cell fate of death (Morshed & Davies, 2015).